ASX Share rice
Sun 16 Aug 2020 - 07:09:am (Sydney)

API Share Price

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITEDAPIHealth Care Equipment & Services

API Company Information

Name:

Australian Pharmaceutical Industries Limited

Sector:

Healthcare

Industry:

Medical Distribution

GIC Industry:

Health Care Providers & Services

GIC Sub Industry:

Health Care Distributors

Address:

250 Camberwell Road Camberwell Australia 3124

Phone:

61 3 8855 3000

MD, CEO & Exec. Director:

Mr. Richard C. Vincent B.Bus, (Accountancy), CPA

Chief Financial Officer:

Mr. Peter Mendo

Chief Information Officer:

Mr. Dean Matthews

Gen. Counsel & Company Sec.:

Ms. Anne Mustow

Gen. Mang. of People:

Mr. Stephen Arthurson

Company Overview:

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 488 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.

API Share Price Information

Shares Issued:

492.66M

Market Capitalisation:

$561.63M

Dividend per Share:

$0.08

Ex Dividend Date:

2019-11-13

Dividend Yield:

7.02%

Revenue (TTM):

$4.07B

Revenue Per Share (TTM):

$8.26

Earnings per Share:

$0.106

Profit Margin:

0.0129

Operating Margin (TTM):

$0.02

Return On Assets (TTM):

$0.03

Return On Equity (TTM):

$0.11

Quarterly Revenue Growth (YOY):

0.028

Gross Profit(TTM):

$518.31M

Diluted Earnings Per Share (TTM):

$0.106

QuarterlyEarnings Growth(YOY):

-0.102

API CashFlow Statement

CashFlow Date:

2019-08-31

Investments:

$-116,539,000

Change To Liabilities:

$7.01M

Total Cashflow From Investing Activities:

$-116,539,000

Net Borrowings:

$135.44M

Net Income:

$55.11M

Total Cash From Operating Activities:

$11.61M

Depreciation:

$17.52M

Other Cashflow From Investing Activities:

$3.53M

Dividends Paid:

$-38,171,000

Change To Inventory:

$-18,039,000

Change To Account Receivables:

$-34,881,000

Capital Expenditures:

$35.70M

API Income Statement

Income Date:

2019-08-31

Income Before Tax:

$73.74M

Net Income:

$55.11M

Gross Profit:

$518.31M

Operating Income:

$66.52M

Other Operating Expenses:

$-18,034,000

Interest Expense:

$20.65M

Income Tax Expense:

$17.16M

Total Revenue:

$4.01B

Total Operating Expenses:

$451.78M

Cost Of Revenue:

$3.49B

API Balance Sheet

Balance Sheet Date:

2019-08-31

Intangible Assets:

$174.35M

Total Liabilities:

$1.14B

Total Stockholder Equity:

$518.92M

Other Current Liabilities:

$15.13M

Total Assets:

$1.67B

Common Stock:

$566.46M

Retained Earnings:

$-110,189,000

Other Liabilities:

$78.50M

Good Will:

$105.93M

Other Assets:

$89.57M

Cash:

$30.18M

Total Current Liabilities:

$887.48M

Short-Term Debt:

$59.31M

Property - Plant & Equipment:

$107.13M

Net Tangible Assets:

$239.62M

Long-Term Investments:

$87.85M

Total Current Assets:

$1.10B

Long-Term Debt:

$169.45M

Net Receivables:

$698.21M

Short-Term Investments:

$563.84M

Inventory:

$413.26M

Accounts Payable:

$790.27M

Non Currrent Assets (Other):

$563.84M

Short-Term Investments:

$563.84

Non Current Liabilities Total:

$255.43M

API Share Price History

API News

23 Jul, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
10 Jun, 2020
Half Year 2020 Australian Pharmaceutical Industries Ltd Earnings Call
08 Apr, 2020
Many investors define successful investing as beating the market average over the long term. But its virtually certain...
16 Mar, 2020
Richard Vincent has been the CEO of Australian Pharmaceutical Industries Limited (ASX:API) since 2017. This analysis...
16 Jan, 2020
Full Year 2019 Australian Pharmaceutical Industries Ltd Earnings Presentation
04 Dec, 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
14 Nov, 2019
Could Australian Pharmaceutical Industries Limited (ASX:API) be an attractive dividend share to own for the long haul...
28 Oct, 2019
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
07 Oct, 2019
Today we are going to look at Australian Pharmaceutical Industries Limited (ASX:API) to see whether it might be an...
17 Sep, 2019
Richard Vincent has been the CEO of Australian Pharmaceutical Industries Limited (ASX:API) since 2017. This analysis...
28 Aug, 2019
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

API Dividend Payments

EX-Date Dividend Amount
2010-05-07$0.0100
2010-11-04$0.0150
2010-11-05$0.0150
2011-05-04$0.0100
2011-11-10$0.0150
2011-11-11$0.0150
2012-05-04$0.0150
2012-11-11$0.0150
2012-11-12$0.0150
2013-05-06$0.0150
2013-11-10$0.0175
2013-11-11$0.0175
2014-05-07$0.0150
2014-11-11$0.0200
2014-11-12$0.0200
2015-05-06$0.0200
2015-11-03$0.0250
2015-11-04$0.0250
2016-05-05$0.0250
2016-11-02$0.0350
2016-11-03$0.0350
2017-05-04$0.0350
2017-11-08$0.0350
2017-11-09$0.0350
2018-05-03$0.0350
2018-11-07$0.0400
2018-11-08$0.0400
2019-05-02$0.0375
2019-11-12$0.0400
2019-11-13$0.0400

API Dividends (last 10 Years)